Publicaciones (52) Publicaciones de ANA ISABEL ARROBA ESPINOSA

2024

  1. Arylphthalide Delays Diabetic Retinopathy via Immunomodulating the Early Inflammatory Response in an Animal Model of Type 1 Diabetes Mellitus

    International Journal of Molecular Sciences, Vol. 25, Núm. 15

  2. Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis

    Journal of Neuroinflammation, Vol. 20, Núm. 1

  2. Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties

    European Journal of Medicinal Chemistry, Vol. 255

  3. Rugulopteryx-Derived Spatane, Secospatane, Prenylcubebane and Prenylkelsoane Diterpenoids as Inhibitors of Nitric Oxide Production

    Marine Drugs, Vol. 21, Núm. 4

2022

  1. A New Perspective on Huntington’s Disease: How a Neurological Disorder Influences the Peripheral Tissues

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  2. Adult kidney explants is a physiologic model for studying diabetic nephropathy

    Life Sciences, Vol. 300

  3. Angiogenic Imbalance and Inflammatory Biomarkers in the Prediction of Hypertension as Well as Obstetric and Perinatal Complications in Women with Gestational Diabetes Mellitus

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  4. Blood Pressure Monitoring and Perinatal Outcomes in Normotensive Women with Gestational Diabetes Mellitus

    Journal of Clinical Medicine, Vol. 11, Núm. 5

  5. IL-1β Implications in Type 1 Diabetes Mellitus Progression: Systematic Review and Meta-Analysis

    Journal of Clinical Medicine, Vol. 11, Núm. 5

  6. Is mouse retinal affectation by HTT cag expansion suitable for modelling the neuroinflammatory component of Huntington’s disease?

    B: Models for HD

  7. Role of long non-coding RNAs in adipose tissue metabolism and associated pathologies

    Biochemical Pharmacology, Vol. 206

  8. Special Issue “The Prevention, Treatment, and Complications of Diabetes Mellitus”

    Journal of Clinical Medicine

  9. Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (Ss)-DS-ONJ

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Anti-Inflammatory (M2) Response Is Induced by a sp2-Iminosugar Glycolipid Sulfoxide in Diabetic Retinopathy

    Frontiers in Immunology, Vol. 12

  2. Diterpenoids from the brown alga rugulopteryx okamurae and their anti-inflammatory activity

    Marine Drugs, Vol. 19, Núm. 12

  3. Synthesis of sp2-Iminosugar Selenoglycolipids as Multitarget Drug Candidates with Antiproliferative, Leishmanicidal and Anti-Inflammatory Properties

    Molecules (Basel, Switzerland), Vol. 26, Núm. 24

2020

  1. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-18

2019

  1. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 7

  2. Synthesis of polyfluoroalkyl sp2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and anti-inflammatory therapies

    European Journal of Medicinal Chemistry, Vol. 182